{"id":"W4206450867","doi":"10.1200/jco.2021.39.15_suppl.tps2074","title":"GBM AGILE: A global, phase 2/3 adaptive platform trial to evaluate multiple regimens in newly diagnosed and recurrent glioblastoma.","year":2021,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Clinical trial; Randomization; Glioblastoma; Agile software development; Dosing; Oncology; Internal medicine; Medical physics; Computer science; Cancer research","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003159081,0.001107178,0.0008655657,0.0004842302,0.0002770944,0.0007486459,0.0006612628,0.0008338041,0.003279943],"category_scores_gemma":[0.001951052,0.0002683812,0.001357175,0.0003660155,0.000925952,0.0008203114,0.001096061,0.002871851,0.0006946824],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008705753,"about_ca_system_score_gemma":0.002173265,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007769476,"about_ca_topic_score_gemma":0.001982774,"domain_scores_codex":[0.9991089,0.0005489485,0.00002972982,0.00009993716,0.0001047115,0.0001078244],"domain_scores_gemma":[0.9992031,0.0001648579,0.0001656461,0.00006121359,0.00005833064,0.0003467781],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.4288659,0.02651675,0.009564028,0.00211198,0.002767972,0.000551656,0.0005122358,0.01425081,0.02394868,0.004621339,0.04873492,0.4375538],"study_design_scores_gemma":[0.586804,0.3362057,0.01756519,0.0005048818,0.001400296,0.0009817668,0.0002260287,0.01152033,0.007860785,0.006171678,0.03063565,0.0001237761],"study_design_candidate":"randomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9469124,0.006420291,0.0112764,0.00566138,0.0007381227,0.009927261,0.005578924,0.001191643,0.01229348],"genre_scores_gemma":[0.9396996,0.003573651,0.02300056,0.007262342,0.0003670269,0.01139653,0.007134336,0.0003025044,0.007263554],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003279943,"threshold_uncertainty_score":0.016707,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1736324325527072,"score_gpt":0.4979826904434111,"score_spread":0.3243502578907039,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}